429 related articles for article (PubMed ID: 9603970)
1. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C?
Luberto C; Hannun YA
J Biol Chem; 1998 Jun; 273(23):14550-9. PubMed ID: 9603970
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of sphingomyelin hydrolysis and resynthesis on the activation of NF-kappa B in normal and SV40-transformed human fibroblasts.
Luberto C; Yoo DS; Suidan HS; Bartoli GM; Hannun YA
J Biol Chem; 2000 May; 275(19):14760-6. PubMed ID: 10799564
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein-mediated cellular lipid release requires replenishment of sphingomyelin in a phosphatidylcholine-specific phospholipase C-dependent manner.
Ito J; Nagayasu Y; Ueno S; Yokoyama S
J Biol Chem; 2002 Nov; 277(47):44709-14. PubMed ID: 12228236
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.
Li Z; Hailemariam TK; Zhou H; Li Y; Duckworth DC; Peake DA; Zhang Y; Kuo MS; Cao G; Jiang XC
Biochim Biophys Acta; 2007 Sep; 1771(9):1186-94. PubMed ID: 17616479
[TBL] [Abstract][Full Text] [Related]
5. Effect of tricyclodecan-9-yl potassium xanthate (D609) on phospholipid metabolism and cell death during oxygen-glucose deprivation in PC12 cells.
Larsen EC; Hatcher JF; Adibhatla RM
Neuroscience; 2007 May; 146(3):946-61. PubMed ID: 17434680
[TBL] [Abstract][Full Text] [Related]
6. Anti-proliferative effects of tricyclodecan-9-yl-xanthogenate (D609) involve ceramide and cell cycle inhibition.
Gusain A; Hatcher JF; Adibhatla RM; Wesley UV; Dempsey RJ
Mol Neurobiol; 2012 Jun; 45(3):455-64. PubMed ID: 22415444
[TBL] [Abstract][Full Text] [Related]
7. Human sphingomyelin synthase 1 generates diacylglycerol in the presence and absence of ceramide via multiple enzymatic activities.
Suzuki R; Murakami C; Dilimulati K; Atsuta-Tsunoda K; Kawai T; Sakane F
FEBS Lett; 2023 Nov; 597(21):2672-2686. PubMed ID: 37715942
[TBL] [Abstract][Full Text] [Related]
8. Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells.
Meng A; Luberto C; Meier P; Bai A; Yang X; Hannun YA; Zhou D
Exp Cell Res; 2004 Jan; 292(2):385-92. PubMed ID: 14697345
[TBL] [Abstract][Full Text] [Related]
9. Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature.
Adibhatla RM; Hatcher JF; Gusain A
Neurochem Res; 2012 Apr; 37(4):671-9. PubMed ID: 22101393
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.
Abalsamo L; Spadaro F; Bozzuto G; Paris L; Cecchetti S; Lugini L; Iorio E; Molinari A; Ramoni C; Podo F
Breast Cancer Res; 2012 Mar; 14(2):R50. PubMed ID: 22429397
[TBL] [Abstract][Full Text] [Related]
11. Sphingomyelin synthase-related protein generates diacylglycerol via the hydrolysis of glycerophospholipids in the absence of ceramide.
Murakami C; Sakane F
J Biol Chem; 2021; 296():100454. PubMed ID: 33621517
[TBL] [Abstract][Full Text] [Related]
12. Progesterone triggers the rapid activation of phospholipase D in the amphibian oocyte plasma membrane when initiating the G2/M transition.
Kostellow AB; Ma GY; Morrill GA
Biochim Biophys Acta; 1996 Dec; 1304(3):263-71. PubMed ID: 8982272
[TBL] [Abstract][Full Text] [Related]
13. Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy.
Barceló-Coblijn G; Martin ML; de Almeida RF; Noguera-Salvà MA; Marcilla-Etxenike A; Guardiola-Serrano F; Lüth A; Kleuser B; Halver JE; Escribá PV
Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19569-74. PubMed ID: 22106271
[TBL] [Abstract][Full Text] [Related]
14. Sphingomyelin synthase 1 activity is regulated by the BCR-ABL oncogene.
Burns TA; Subathra M; Signorelli P; Choi Y; Yang X; Wang Y; Villani M; Bhalla K; Zhou D; Luberto C
J Lipid Res; 2013 Mar; 54(3):794-805. PubMed ID: 23160178
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial ceramide increases in UV-irradiated HeLa cells and is mainly derived from hydrolysis of sphingomyelin.
Dai Q; Liu J; Chen J; Durrant D; McIntyre TM; Lee RM
Oncogene; 2004 Apr; 23(20):3650-8. PubMed ID: 15077187
[TBL] [Abstract][Full Text] [Related]
16. Ceramide does not inhibit protein kinase C beta-dependent phospholipase D activity stimulated by anti-Fas monoclonal antibody in A20 cells.
Han J; Shin I
Cell Signal; 2000 Dec; 12(11-12):731-6. PubMed ID: 11152958
[TBL] [Abstract][Full Text] [Related]
17. Role of ceramide/sphingomyelin (SM) balance regulated through "SM cycle" in cancer.
Taniguchi M; Okazaki T
Cell Signal; 2021 Nov; 87():110119. PubMed ID: 34418535
[TBL] [Abstract][Full Text] [Related]
18. Sphingomyelin Synthase Family and Phospholipase Cs.
Jiang XC; Chiang YP
Adv Exp Med Biol; 2022; 1372():77-86. PubMed ID: 35503176
[TBL] [Abstract][Full Text] [Related]
19. Role of sphingomyelin synthesis in pulmonary endothelial cell cytoskeletal activation and endotoxin-induced lung injury.
Anjum F; Joshi K; Grinkina N; Gowda S; Cutaia M; Wadgaonkar R
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):94-103. PubMed ID: 22362386
[TBL] [Abstract][Full Text] [Related]
20. Increase of nuclear ceramide through caspase-3-dependent regulation of the "sphingomyelin cycle" in Fas-induced apoptosis.
Watanabe M; Kitano T; Kondo T; Yabu T; Taguchi Y; Tashima M; Umehara H; Domae N; Uchiyama T; Okazaki T
Cancer Res; 2004 Feb; 64(3):1000-7. PubMed ID: 14871831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
